Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for Kidney Lesion Diagnosis in CKD
NCT02684435Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2016
- Primary completion
- Jul 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in kidney cancer, sponsored by University of North Carolina at Chapel Hill. Started Feb 2016; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT02684435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684435.